Also see: Dendreon, Tiffany: Analysts' New Ratings
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES
Agrium (AGU) estimates, target raised at UBS. Shares of AGU now seen reaching $115. Estimates also raised on improving gross margins in all three strategic business units. Buy rating.Arcos Dorados (ARCO) estimates, target increased at Citigroup. Shares of ARCO now seen reaching $32. Estimates also raised on NOLAD turnaround and margin boosts. Buy rating. Atmel (ATML) estimates, target lowered at UBS. Shares of ATML now seen reaching $18. Estimates also lowered as weaker macro slows growth. Buy rating. Activision Blizzard (ATVI - Get Report) estimates higher at UBS. TVI estimates were raised through 2012. New digital business models enhance margin, drive growth. Maintain $14 price target and Buy rating. Bruker (BRKR) estimates, target lowered at UBS. Shares of BRKR now seen reaching $21. Estimates also lowered on higher SG&A costs. Buy rating. Cott (COT) estimates lowered at UBS through 2011. Gross margins decline amid higher commodity costs. Maintain $10 price target and Buy rating. Cisco (CSCO - Get Report) target lowered at Citigroup to $17.50. Restructuring and macro headwinds weight on NT outlook. Hold rating. Duke Energy (DUK) numbers boosted at Credit Suisse. Shares of DUK now seen reaching $19. Estimates also upped, to match the company's new guidance. Neutral rating. DaVita estimates raised at UBS through 2012. Solid guidance and lower EPO/better Medicare rate. Maintain $100 price target and Buy rating. Emerson (EMR - Get Report) estimates, target cut at Credit Suisse. EMR estimates were reduced through 2013. Company is leveraged to lower macroeconomic growth. Outperform rating and new $59 price target. Genpact (G - Get Report) estimates, target increased at Citigroup. Shares of G now seen reaching $18. Estimates also raised on strong 2Q. Hold rating. Hewlett-Packard (HPQ - Get Report) numbers reduced at Barclays. Shares of HPQ now seen reaching $37. Estimates also cut, given lower PC demand. Equal-weight rating. IntercontinentalExchange (ICE - Get Report) numbers cut at Barclays. Shares of ICE now seen reaching $148. Estimates also lowered, given the company's new volume forecast. Overweight rating. ICE estimates, target lowered at UBS. Shares of ICE now seen reaching $140, according to UBS. Estimates also lowered on updated volume assumptions. Buy rating.